Da‐Qiang Li

10.8k citations
106 papers · 8.5k · 6 hit papers · h-index 40

Impact in

    • Breast Cancer Treatment Studies
    • Cancer, Hypoxia, and Metabolism
  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • Cancer Cells and Metastasis

Papers in

    • Breast Cancer Treatment Studies 14
    • Mechanisms of cancer metastasis 13
    • Ubiquitin and proteasome pathways 12
    • Chromatin Remodeling and Cancer 12
    • DNA Repair Mechanisms 9
    • RNA Research and Splicing 6
    • Genomics and Chromatin Dynamics 6

Da‐Qiang Li

105 papers receiving 8.4k citations

Da‐Qiang Li's Hit Papers

Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy 2022 · 503 citations
5030+2+4Years since publication5001k1.5k2k

Peers

Da‐Qiang Li
Comparison fields: 5 of 132
  • Cancer Research 1.6k
  • Oncology 1.1k
  • Molecular Biology 2.9k
  • Epidemiology 1.1k
  • Pulmonary and Respiratory Medicine 772
Replace Viji Shridhar with:
Viji Shridhar United States
Ruey‐Hwa Chen Taiwan
Tianhua Zhou China
Sufi Mary Thomas United States
Jianjun Shen United States
Sara R. Zanivan United Kingdom
Thomas G. Hofmann Germany
Andrei L. Gartel United States
Maria Laura Avantaggiati United States
Da‐Qiang Li relative to Viji Shridhar United States Viji Shridhar's profile →
Citations per field
00.5×1.5×2.2×
Viji Shridhar · 1×
Citations per year

Countries citing papers authored by Da‐Qiang Li

Since Specialization
Citations

This map shows the geographic impact of Da‐Qiang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Da‐Qiang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Da‐Qiang Li more than expected).

Fields of papers citing papers by Da‐Qiang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Da‐Qiang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Da‐Qiang Li. The network helps show where Da‐Qiang Li may publish in the future.

Co-authors

The 25 scholars most cited alongside Da‐Qiang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Da‐Qiang Li Line = papers co-authored together Da‐Qiang Li links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 106 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
Hit paper breakdown →
20212067
2
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies
Hit paper breakdown →
2019759
3
Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy
Hit paper breakdown →
2022503
4 2009440
5
Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets
Hit paper breakdown →
2020350
6
The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer
Hit paper breakdown →
2022345
7
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
Hit paper breakdown →
2022251
8 2016184
9 2020159
10 2007157
11 2006124
12 2012123
13 2012119
14 2019104
15 201299
16 201891
17 201988
18 201886
19 200978
20 201378

About Da‐Qiang Li

Da‐Qiang Li is a scholar working on Cancer Research, Molecular Biology, Oncology, Cell Biology and Pulmonary and Respiratory Medicine, having authored 106 papers that have together received 8.5k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (14 papers), Mechanisms of cancer metastasis (13 papers), Ubiquitin and proteasome pathways (12 papers), Chromatin Remodeling and Cancer (12 papers), DNA Repair Mechanisms (9 papers), RNA Research and Splicing (6 papers), Genomics and Chromatin Dynamics (6 papers) and Autophagy in Disease and Therapy (5 papers). The work is most often cited by research in Cancer Research (1.6k citations), Oncology (1.1k citations), Molecular Biology (2.9k citations), Epidemiology (1.1k citations) and Pulmonary and Respiratory Medicine (772 citations). Da‐Qiang Li has collaborated with scholars based in China, United States and India. Frequent co-authors include Rakesh Kumar, Yi‐Zhou Jiang, Xi Jin, Xin Hu, Ding Ma, Sujit S. Nair, Zhi‐Ming Shao, Fang-Lin Zhang, Suresh B. Pakala and Yi Xiao. Their work appears in journals such as Cancer Research, Journal of Biological Chemistry, Cancer Letters, Clinical and Translational Medicine and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact